Last reviewed · How we verify
NCT05837611
Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking
NA trial testing Deposit Contract in Alcohol Abuse in 80 participants. Status unknown.
31 May 2024
Quick facts
| Lead sponsor | University of North Texas, Denton, TX |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 10 June 2022 |
| Primary completion | 31 May 2024 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Deposit Contract
- Transdermal Alcohol Monitoring
Conditions studied
- Alcohol Abuse — all drugs for Alcohol Abuse →
- Alcohol Intervention — all drugs for Alcohol Intervention →
- Transdermal Alcohol Monitoring — all drugs for Transdermal Alcohol Monitoring →
- Contingency Management — all drugs for Contingency Management →
Sponsor
University of North Texas, Denton, TX
Who can join
21 and older, any sex, with Alcohol Abuse or Alcohol Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine the effects of an incentive-based intervention (for reducing alcohol use) that would be sustainable, easily accessible intervention using remote alcohol monitoring and deposit contracts, targeting individuals who would not be reached by more traditional forms of treatment due to barriers such as time constraints, attitudes, and stigma.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05837611
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Abuse
Currently open trials in the same condition.
- NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
- NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use · NA · recruiting
- NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
- NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
- NCT06265506 — Virtual Incentive Treatment for Alcohol · NA · recruiting
Other University of North Texas, Denton, TX trials
Trials by the same sponsor.
- NCT06506097 — Family-school Partnership Intervention for Early Childhood Education · NA · recruiting
- NCT05523453 — Examining Effects of a Therapeutic Focus on Positive Memories on Post-Trauma Health · NA · completed
- NCT05712408 — Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis · NA · completed
- NCT05641389 — Improving Remote Breathalyzer Procedures Used by Clinicians and Researchers to Remotely Monitor Alcohol Use · recruiting
- NCT05571605 — Cerebrovascular Dysregulation in Chronic Kidney Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05837611 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Texas, Denton, TX
- Last refreshed: 6 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837611.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing